Anhui Fengyuan Pharmaceutical Co., Ltd.
000153.SZ · SHZ
Market closed5.54-0.250000 (-4.32%)
Key statistics
Previous close5.79
Open5.65
Day high5.83
Day low5.54
52-week high8.08
52-week low4.95
Market cap2.57B
Volume8.97M
Average volume8.63M
P/E ratio18.81
Forward P/E—
EPS0.29
Dividend yield+1.81%
Market context
Why it moved
Broad market selling pressure and a risk-off sentiment weighed on 000153.SZ, driving the stock sharply lower from its previous close amid elevated volume suggesting significant investor exits.
What is happening
Recent company-specific developments and publisher coverage.
finance.biggo.com · July 12, 2026Fengyuan Pharmaceutical's Control Set to Change: Concerted Parties to Exit in approximately $103.6 Million Deal, Bengbu State Capital Likely Buyer富途牛牛 · July 10, 2026Fengyuan Pharmaceutical's controlling stake may change hands as Bengbu Investment Group plans to take control with a RMB 7 billion investment | Quick Read Announcementwww.marketscreener.com · July 9, 2026BengBu Investment Group Co.,Ltd entered into a Share Transfer Intent Agreement to acquire 23.52% stake in Anhui Fengyuan Pharmaceutical Co., Ltd. from Anhui Bangbu Tushan Pharmaceutical Factory, Anhui Maanshan Biochemical Pharmaceutical Factormarketscreener.com · April 28, 2026Anhui Fengyuan Pharmaceutical Co., Ltd. announces Annual dividend, payable on June 18, 2026 Mt Newswire · May 13, 2026Fengyuan Pharma's Unit Gets Nod for Marketing of Vonoprazan Fumarate Mt Newswire · May 8, 2026Anhui Fengyuan Pharmaceutical Gets China Regulatory Approval for Pediatric Constipation Drug